missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ CPI 203

Click to view available options
Quantity:
10 mg
Unit Size:
10mg
Description
CPI 203 is a BET bromodomain inhibitor. Downregulates Myc expression, causes G1 cell cycle arrest and attenuates cell proliferation in human pancreatic neuroendocrine tumors. Arrests the growth of T cell acute lymphoblastic leukemia cells in vitro (EC50 = 91.2 nM). Also enhances the antitumor effect of rapamycin (Cat. No. 1292) in vitro and attenuates rapamycin induced Akt activation. Also enhances fibroblast reprogramming to hiPSCs at low concentration. Orally bioavailable.
Specifications
Specifications
| Quantity | 10 mg |
| Product Type | CPI 203 |
| Purity | >98% |
| Molecular Weight (g/mol) | 399.9 |
| Inhibitors | CPI 203 |
For Research Use Only
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction